Antitumour activity of docetaxel following treatment with the CYP17A1 inhibitor abiraterone: clinical evidence for cross-resistance? — Janusz Mezynski (2012) | RDL Network
Janusz Mezynski, G. Attard, Andrea Zivi, Diletta Bianchini, Shahneen Sandhu, Amy Mulick, Erik W. Thompson, A. Reid, Bindumalini Rao Baikady, Johann S. de Bono
Yohann Loriot, Diletta Bianchini, E. Ileana, Shahneen Sandhu, Anna Patrikidou, Carmel Pezaro, Laurence Albigès, Gerhardt Attard, Karim Fizazi, Johann S. de Bono, Christophe Massard
Aurelius Omlin, Carmel Pezaro, S. Zaidi, David Lorente, Deborah Mukherji, Diletta Bianchini, Roberta Ferraldeschi, Shahneen Sandhu, David P. Dearnaley, Chris Parker, Nicholas van As, Johann S. de Bono, Gerhardt Attard
Gustavo E. Chavarria, Michael R. Horsman, Wara M. Arispe, G.D. Kishore Kumar, Shenen Chen, Tracy E. Strecker, Erica N. Parker, David J. Chaplin, Kevin G. Pinney, Mary Lynn Trawick
Jane Goodall, Alexa Gillman, Helen Mossop, Christy Ralph, Zafeiris Zafeiriou, Raquel Pérez López, Nina Tunariu, Roberta Ferraldeschi, Daniel Nava Rodrigues, Lakshmi P. Kunju, Dan R. Robinson, Gerhardt Attard, Arul M. Chinnaiyan, Johann S. de Bono, Joaquı́n Mateo, Emma Hall, Shahneen Sandhu, Aurelius Omlin, Susana Miranda, Suzanne Carreira
Discussion(0)
No comments yet. Be the first to comment.